Exelixis Inc(EXEL-Q)NASDAQ
Today's Change
Real-Time Last Update
Pre Market Change
Pre Market Last Update
Volume
Exelixis Inc
1851 Harbor Bay ParkwayAlameda CA 94502 USA
P: 650-837-7000
F: 650-837-8300
http://www.exelixis.com
Sectors & Indices
Sector
Industry
Employees
Profile
Exelixis, Inc. is an oncology-focused biotechnology company, which primarily focuses on the discovery, development and commercialization of new drugs for the treatment of difficult-to-treat cancers. The company has four approved drugs in its portfolio. Of these, two are derived from cabozantinib, the company's flagship molecule, which is an inhibitor of multiple tyrosine kinases, including MET, AXL, VEGF receptors and RET.
Key Executives
| Name | Title |
|---|---|
| Information not available. | |